SCHEMBL16249333

SCHEMBL16249333

CC(C)(C)OC(=O)N(Cc1ccc(-c2ccccc2)cc1)C1CCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.49
LTB4R2 Q9NPC1 1/20 0.47
AGER Q15109 3/20 0.45
MTNR1A P48039 1/20 0.45
HRH4 Q9H3N8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
GPR119 Q8TDV5 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
ENPP2 Q13822 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
USP30 Q70CQ3 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27884072 0.91 AGER (0.54) HSD11B1LTB4R2AGERMTNR1AHDAC3
SCHEMBL10207431 0.91 HSD11B1 (0.56) HSD11B1AGERMTNR1ANR1H4HDAC3
Formic Acid SCHEMBL28071336 0.86 HSD11B1 (0.53) HSD11B1AGERMTNR1ANR1H4HDAC3
SCHEMBL3117999 0.85 AGER (0.48) HSD11B1LTB4R2AGERMTNR1AGPR119
SCHEMBL13267029 0.85 GPR119 (0.50) HSD11B1LTB4R2NR1H4GPR119HDAC3
SCHEMBL14897752 0.85 HSD11B1 (0.48) HSD11B1NR1H4GPR119HDAC3HDAC1
SCHEMBL21088550 0.85 HTR2A (0.44) HSD11B1AGERMTNR1ANR1H4HDAC3
SCHEMBL3143765 0.84 HSD11B1 (0.43) HSD11B1LTB4R2AGERMTNR1AHRH4
SCHEMBL2586550 0.84 HSD11B1 (0.43) HSD11B1LTB4R2AGERMTNR1AHRH4
SCHEMBL5145400 0.83 HSD11B1 (0.44) HSD11B1AGERMTNR1AGPR119HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140343019-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2014-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343019-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT1 HSD11B1 1790/4885LTB4R2 2260/4885AGER 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.